Dr. Egnaczyk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2123 Auburn Ave
Ste 137
Cincinnati, OH 45219Phone+1 513-206-1180Fax+1 513-206-1182
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 2006 - 2010
- Massachusetts General HospitalResidency, Internal Medicine, 2003 - 2006
- University of Cincinnati College of MedicineClass of 2003
Certifications & Licensure
- KY State Medical License 2013 - 2025
- NC State Medical License 2024 - 2025
- OH State Medical License 2010 - 2025
- PA State Medical License 2024 - 2024
- MA State Medical License 2005 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow in the American College of Cardiology ACC, 2011
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Tolvaptan/Ultrafiltration in the Treatment of Acute Heart Failure Start of enrollment: 2013 May 01
- PREVENtion of HeartMate II Pump Thrombosis Start of enrollment: 2014 Sep 01
Publications & Presentations
PubMed
- 10 citationsCOMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device.Steven R Allen, Mark S Slaughter, Mustafa M Ahmed, Carlo R Bartoli, Ravi Dhingra
The Journal of Heart and Lung Transplantation. 2023-01-01 - 150 citationsEfficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart FailureG. Michael Felker, Robert J. Mentz, Robert T. Cole, Kirkwood F. Adams, Gregory F. Egnaczyk
Journal of the American College of Cardiology. 2017-03-21 - 8 citationsPREVENTion of non-surgical bleeding by management of HeartMate II patients without anti-platelet therapy (PREVENT II) trialUlrich P. Jorde, Jason N. Katz, Paolo C. Colombo, John M. Stulak, Omar Saeed
The Journal of Heart and Lung Transplantation. 2020-08-01
Press Mentions
- 2023 Health Care Heroes Finalist: Dr. Gregory EgnaczykFebruary 16th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: